Protecting the oral mucosa in patients with oral tongue squamous cell carcinoma treated postoperatively with intensity-modulated radiotherapy: A randomized study

Laryngoscope

Volumn 122, Issue 2, 2012, Pages 291-298

  Wang, Zhong He ^a   Zhang, Shi Zhou ^c   Zhang, Zhi Yuan ^b   Zhang, Chen Ping ^b   Hu, Hai Sheng ^a   Tu, Wen Yong ^a   Kirwan, Jessica ^d   Mendenhall, William M ^d  

^a Division of Radiation Oncology   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^c SHANDONG UNIVERSITY   (China)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Acute mucositis; Level of Evidence: 2c; oral sparing; oral tongue cancer; postoperative intensity modulated radiotherapy

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT;

ADULT; AGED; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOSIMETRY; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; MOUTH MUCOSA; MUCOSA INFLAMMATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SAFETY; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 84862817048     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.22434     Document Type: Article

References (19)

1. Vera-Llonch M, Oster G, Hagiwara M, Sonis S,. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer 2006; 106: 329-336. (Pubitemid 43100441)
2. Elting LS, Cooksley CD, Chambers MS, Garden AS,. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys 2007; 68: 1110-1120. (Pubitemid 47048578)
3. Elting LS, Keefe DM, Sonis ST, et al. Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life. Cancer 2008; 113: 2704-2713.
4. Lalla RV, Sonis ST, Peterson DE,. Management of oral mucositis in patients who have cancer. Dent Clin North Am 2008; 52: 61-77, viii.
5. Wang ZH, Zhang ZY, Mendenhall WM,. Postoperative radiotherapy after titanium plate mandibular reconstruction for oral cavity cancer. Am J Clin Oncol 2005; 28: 460-463. (Pubitemid 41437384)
6. Wang Z, Qiu W, Mendenhall WM,. Influence of radiation therapy on reconstructive flaps after radical resection of head and neck cancer. Int J Oral Maxillofac Surg 2003; 32: 35-38. (Pubitemid 36284850)
7. Wang ZH, Yan C, Zhang ZY, et al. Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study. Int J Radiat Oncol Biol Phys. In press.
8. Saarilahti K, Kouri M, Collan J, et al. Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer. Radiother Oncol 2006; 78: 270-275.
9. Wang ZH, Yan C, Zhang ZY, et al. Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study. Laryngoscope 2009; 119: 1966-1974.
10. Cancer therapy evaluation program. Common Terminology Criteria for Adverse Events version 3.0 (CTCAE). August 9, 2006. Available at: http://ctep.cancer.gov/protocolDevelopment/electronic-applications/docs/ctcaev3. pdf Accessed March 4, 2007.
11. Trotti A, Bellm LA, Epstein JB, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 2003; 66: 253-262. (Pubitemid 36556043)
12. Gomez DR, Zhung JE, Gomez J, et al. Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers. Int J Radiat Oncol Biol Phys 2009; 73: 1096-1103.
13. Sanguineti G, Endres EJ, Gunn BG, Parker B,. Is there a "mucosa-sparing" benefit of IMRT for head-and-neck cancer? Int J Radiat Oncol Biol Phys 2006; 66: 931-938. (Pubitemid 44436706)
14. Narayan S, Lehmann J, Coleman MA, et al. Prospective evaluation to establish a dose response for clinical oral mucositis in patients undergoing head-and-neck conformal radiotherapy. Int J Radiat Oncol Biol Phys 2008; 72: 756-762.
15. Wygoda A, Maciejewski B, Skladowski K, et al. Pattern analysis of acute mucosal reactions in patients with head and neck cancer treated with conventional and accelerated irradiation. Int J Radiat Oncol Biol Phys 2009; 73: 384-390.
16. Seung S, Bae J, Solhjem M, et al. Intensity-modulated radiotherapy for head-and-neck cancer in the community setting. Int J Radiat Oncol Biol Phys 2008; 72: 1075-1081.
17. Madani I, Vakaet L, Bonte K, Boterberg T, De Neve W,. Intensity-modulated radiotherapy for cervical lymph node metastases from unknown primary cancer. Int J Radiat Oncol Biol Phys 2008; 71: 1158-1166.
18. Sonis ST, Eilers JP, Epstein JB, et al. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group. Cancer 1999; 85: 2103-2113. (Pubitemid 29215547)
19. Epstein JB, Gorsky M, Guglietta A, Le N, Sonis ST,. The correlation between epidermal growth factor levels in saliva and the severity of oral mucositis during oropharyngeal radiation therapy. Cancer 2000; 89: 2258-2265.